There has only been a single reported case of a patient with advanced MCC carrying a known PI3K mutation successfully treated with idelalisib, a PI3K-δ inhibitor, resulting in a rapid and complete remission [195]. Here, PIK3CA is linked to Merkel cell skin cancer.